Daily Medical Update

Hypertensive urgency and emergency

Thursday, August 13, 2026

🔬 Practice-Changing Findings
Evidence from RCTs and meta-analyses published in the last 12 months.

1. Comparative Efficacy and Safety of Clevidipine Versus Nicardipine in Hypertensive Emergencies: A Systematic Review and Meta-Analysis.

Clinical cardiology (2026) - Meta-Analysis

Key Findings

  • Across 9 studies involving 1,378 patients, clevidipine and nicardipine did not differ significantly in time to target systolic blood pressure, time within target range, length of stay, hypotension, tachycardia, acute kidney injury, rescue therapy, or in-hospital mortality.
  • Clevidipine achieved target systolic blood pressure faster in stroke/neurocritical-care and general hypertensive-crisis subgroups and was associated with significantly reduced infusion drug volume.

📋 Practice Implication: Use clevidipine and nicardipine as broadly comparable options; favor clevidipine when lower infusion volume or rapid titration is particularly useful, while recognizing that consistent overall superiority was not demonstrated.

2. Efficacy and safety of clevidipine emulsion injection compared with nicardipine in patients with hypertensive emergencies: a randomized, single-blind, positive-parallel-controlled, phase III clinical trial.

Journal of hypertension (2025) - RCT

Key Findings

  • Within 30 minutes, 100.0% of patients receiving clevidipine achieved a 15-25% systolic blood pressure reduction versus 95.9% receiving nicardipine, meeting the prespecified noninferiority criterion.
  • Median time to target was 9 minutes with clevidipine versus 12 minutes with nicardipine, while overall adverse-event rates were similar.

📋 Practice Implication: For a hypertensive emergency requiring prompt, controllable reduction, clevidipine is a reasonable alternative to nicardipine and may reach the initial target several minutes sooner without an apparent safety penalty.

3. Undetected acute hypertension-mediated organ damage: a very important but insufficiently recognized problem.

Expert review of cardiovascular therapy (2025) - Review

Key Findings

  • The review identifies unrecognized acute hypertension-mediated organ damage as increasing the risk of false-negative classification of hypertensive emergency as hypertensive urgency.
  • It concludes that hypertensive emergencies carry substantial cardiovascular-event and mortality risk, with undetected organ damage expected to have an even worse prognosis.

📋 Practice Implication: A negative or incomplete initial assessment should not end the evaluation; actively reassess for acute organ injury before labeling severe blood pressure elevation as urgency and withholding emergency-level treatment.

4. HIgh versus STAndard blood Pressure target in hypertensive high-risk patients undergoing elective major abdominal surgery: the HISTAP multicenter randomized clinical trial.

Intensive care medicine (2026) - Multicenter RCT

Key Findings

  • Among 630 analyzed high-risk hypertensive surgical patients, the composite of postoperative mortality or major organ dysfunction occurred in 38.1% with intraoperative MAP ≥80 mmHg versus 48.9% with MAP ≥65 mmHg (relative risk 0.78; P=0.006).
  • Acute kidney injury occurred less often with the higher MAP target (23.5% vs 33.7%; P=0.005).

📋 Practice Implication: During monitored major abdominal surgery in high-risk patients with chronic hypertension, targeting MAP ≥80 mmHg may reduce postoperative organ dysfunction, especially acute kidney injury, when paired with protocolized hemodynamic management.

5. Outcomes of patients with hypertensive emergency managed in intensive vs intermediate care settings: a multihospital retrospective cohort study.

Annals of the American Thoracic Society (2026) - Retrospective Cohort

Key Findings

  • In adjusted analyses of 649 ICU and 629 intermediate-care patients, the difference in time to hospital discharge was only +0.29 days (95% CI, -0.07 to 0.70), with no difference in readmission or hospital mortality.
  • Intermediate-care patients reached blood pressure targets in similar time, whereas hypotensive episodes during the first 24 hours were increased in the ICU.

📋 Practice Implication: For carefully selected, nonventilated patients without major acute coronary, aortic, or cerebrovascular exclusions, intermediate care can be considered instead of ICU while preserving close blood pressure monitoring and escalation capacity.

💡 Summary

Recent evidence emphasizes precise separation of hypertensive emergency from urgency by identifying acute hypertension-mediated organ damage, while supporting carefully titratable intravenous therapy when emergency treatment is required. Clevidipine and nicardipine had broadly comparable overall outcomes, but higher intraoperative MAP targets reduced postoperative organ dysfunction in high-risk hypertensive surgical patients and selected patients with hypertensive emergency may be managed safely in intermediate care.

Generated from 120 PubMed abstracts · RCTs and Meta-analyses only

Next topic: Adrenal masses and nodules

Unsubscribe  ·  Subscribe